{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T07:32:16Z","timestamp":1697873536045},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/jcp.0b013e318270dea9","type":"journal-article","created":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T10:17:20Z","timestamp":1352197040000},"page":"814-819","source":"Crossref","is-referenced-by-count":4,"title":["Enhanced Ziprasidone Combination Therapy Effectiveness in Obese Compared to Nonobese Patients With Bipolar Disorder"],"prefix":"10.1097","volume":"32","author":[{"given":"Shefali","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pichai","family":"Ittasakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po W.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley J.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith E.","family":"Childers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Rasgon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence A.","family":"Ketter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":". Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"R3-14-20210128","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.4088\/JCP.v64n1205","article-title":"Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.","volume":"64","author":"Keck","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R4-14-20210128","first-page":"650","article-title":"Ruzickova M, et al..","volume":"11","author":"Calkin","year":"2009","journal-title":"Can body mass index help predict outcome in patients with bipolar disorder Bipolar Disord"},{"key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1176\/appi.ajp.160.1.112","article-title":". Obesity as a correlate of outcome in patients with bipolar I disorder.","volume":"160","author":"Fagiolini","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1399-5618.2010.00823.x","article-title":". Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrinemetabolic system and treatment outcome.","volume":"12","author":"Kemp","year":"2010","journal-title":"Bipolar Disord"},{"key":"R7-14-20210128","first-page":"175","article-title":"Wang PW, et al..","volume":"123","author":"Ketter","year":"2011","journal-title":"Treatments for bipolar disorder: can number needed to treatharm help inform clinical decisions Acta Psychiatr Scand"},{"key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","article-title":". Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.","volume":"160","author":"Keck","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.jcp.0000169068.34322.70","article-title":". Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.","volume":"25","author":"Potkin","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4088\/JCP.09m05482yel","article-title":". Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.","volume":"71","author":"Bowden","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R11-14-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.schres.2009.09.023","article-title":". Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder.","volume":"115","author":"Citrome","year":"2009","journal-title":"Schizophr Res"},{"key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4088\/JCP.08m04045","article-title":". Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania.","volume":"70","author":"Keck","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.jcp.0000095347.32154.08","article-title":". Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone.","volume":"23","author":"Weiden","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/JCP.0b013e31819294cb","article-title":". Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.","volume":"29","author":"Morrato","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/S0006-3223(03)00165-3","article-title":". Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).","volume":"53","author":"Sachs","year":"2003","journal-title":"Biol Psychiatry"},{"key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1034\/j.1399-5618.2002.01195.x","article-title":"A clinical monitoring form for mood disorders.","volume":"4","author":"Sachs","year":"2002","journal-title":"Bipolar Disord"},{"key":"R17-14-20210128","first-page":"72","article-title":". Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder.","volume":"40","author":"Dennehy","year":"2007","journal-title":"Psychopharmacol Bull"},{"key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jpsychires.2011.01.019","article-title":". Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients.","volume":"45","author":"Wang","year":"2011","journal-title":"J Psychiatr Res"},{"key":"R20-14-20210128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.08m04301","article-title":"3rd, Kurita K, et al.. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.","volume":"70","author":"Goldberg","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R21-14-20210128","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4088\/JCP.08m04811yel","article-title":". Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.","volume":"71","author":"Post","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R22-14-20210128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/NDT.S9932","article-title":"The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder.","volume":"7","author":"Bowden","year":"2011","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e318270dea9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:00:21Z","timestamp":1620957621000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201212000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318270dea9","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}